i-Base home
Search Menu
  • Home
  • HTB
  • 2018
  • March
  • 14

HTB

14 March 2018

Contents

Editorial

  • 14 March 2018: vol 19 no 5 – CROI 2018 part 1

Conference reports

  • 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018)
  • Inching towards an HIV cure: bNAb and TLR-7 agonist reduce viral rebound off-ART in macaques
  • No HIV evolution in plasma or lymph nodes on suppressive ART and no impact from further intensification
  • Dual therapy can reduce TB prophylaxis from nine months to one: fewer side effects and more people complete treatment
  • Twice-daily dolutegravir is effective and tolerable with rifampicin 
  • Once-daily tenofovir alafenamide appears sufficient when dosed with rifampicin
  • Efavirenz 400 mg can be given with anti-tuberculosis treatment 
  • Bictegravir at CROI 2018: switching studies and drug resistance analyses
  • PrEP at CROI 2018 (part 1): Access in Australia and the US
  • PrEP at CROI 2018 (part 2): Animal studies for future drugs
  • BHIVA best of CROI feedback workshops

Antiretrovirals

  • FDA approves ibalizumab in the US to treat multidrug HIV resistance

PDFs

  • 14 March 2018: vol 19 no 5
  • HTB RSS

Early access

  • Outcomes of 54 cases of monkeypox (MPX) in London: fewer early symptoms but higher rates of genital lesions – urgency of funding sexual health 2 July 2022
  • All early access reports

Current issues

  • July 2022
  • June 2022
  • May 2022
  • Back issues

Special report

  • Monkeypox crisis in the UK needs urgent funding: sex, vaccines and Pride 1 July 2022

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

This site complies with the HONcode standard for trustworthy health information.

Verify here.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
107 The Maltings, 169 Tower Bridge Road, London SE1 3LJ.
Tel + 44 (0) 208 616 2210. Email admin@i-base.org.uk
Registered charity no: 1081905. Company reg no: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Advocate
Professional
Donate
Feedback
Advice and information
Q and A
Phoneline
Pocket info
Guides
HIV meds
Glossary
Research and conference reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
News and updates
News
Blogs
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
Sitemap
Home
Find us on Facebook
i-Base on Facebook